Clinical trials
Phase 2 Parkinson Disease trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 6 |
| 2011 | 5 |
| 2012 | 3 |
| 2013 | 1 |
| 2016 | 8 |
| 2017 | 2 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 38 |
| Active, not recruiting | 5 |
| Terminated | 5 |
| Unknown status | 4 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| University Hospital, Toulouse | 5 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Biogen | 2 |
| Hoffmann-La Roche | 2 |
| Integrative Research Laboratories AB | 2 |
| Pfizer | 2 |
| Sanofi | 2 |
| UCB Biopharma SRL | 2 |
| University Hospital, Clermont-Ferrand | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 54 |
| Dyskinesias | 9 |
| Movement Disorders | 5 |
| Parkinsonian Disorders | 4 |
| Disruptive, Impulse Control, and Conduct Disorders | 3 |
| Neurodegenerative Diseases | 3 |
| Central Nervous System Diseases | 2 |
| Basal Ganglia Diseases | 1 |
| Brain Diseases | 1 |
| Dementia | 1 |
Trials
Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.